Wegovy cuts risk of major heart events in large study

International research involving 17,000 patients found that the weight loss drug Wegovy lowered the risk of heart attacks, strokes, and heart attack-induced death. The drug also facilitated a 9% average weight loss. This indicates the first proven medication for obesity for reducing cardiovascular risk. However, costs and potential side effects are concerns, and more research is necessary to understand the drug’s heart impact.